Clinically Administered Doses of Pitavastatin and Rosuvastatin: Effects on Myocardial Hypertrophy Using Cultured Cardiomyocytes

Clinical studies have indicated that 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, also known as statins, can potentially inhibit chronic heart failure. In the Stat-LVDF study, a difference was noted in terms of the effect of lipophilic pitavastatin (PTV) and hydrophilic rosu...

Ausführliche Beschreibung